Rank | Gene Set | Z-score |
---|---|---|
1 | cellular response to cadmium ion (GO:0071276) | 9.28523679 |
2 | nucleobase-containing small molecule interconversion (GO:0015949) | 4.64907360 |
3 | membrane raft organization (GO:0031579) | 4.61617485 |
4 | type B pancreatic cell proliferation (GO:0044342) | 4.52932600 |
5 | hemidesmosome assembly (GO:0031581) | 4.49646927 |
6 | ribosomal small subunit biogenesis (GO:0042274) | 4.45077010 |
7 | regulation of metalloenzyme activity (GO:0048552) | 4.20103032 |
8 | response to cadmium ion (GO:0046686) | 4.12479062 |
9 | * response to zinc ion (GO:0010043) | 4.00379549 |
10 | protein maturation by protein folding (GO:0022417) | 3.96496635 |
11 | ribosomal large subunit biogenesis (GO:0042273) | 3.95228422 |
12 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 3.91100770 |
13 | pyrimidine nucleoside salvage (GO:0043097) | 3.77716588 |
14 | pyrimidine-containing compound salvage (GO:0008655) | 3.77716588 |
15 | negative regulation of response to reactive oxygen species (GO:1901032) | 3.68852625 |
16 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.66480471 |
17 | fibrinolysis (GO:0042730) | 3.60059692 |
18 | protein heterotetramerization (GO:0051290) | 3.52649098 |
19 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.44081744 |
20 | cell adhesion mediated by integrin (GO:0033627) | 3.43476993 |
21 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.41567615 |
22 | proteasome assembly (GO:0043248) | 3.31788048 |
23 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.30153381 |
24 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.29180039 |
25 | protein targeting to ER (GO:0045047) | 3.28568340 |
26 | nucleoside salvage (GO:0043174) | 3.26146989 |
27 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.25418623 |
28 | cotranslational protein targeting to membrane (GO:0006613) | 3.23616671 |
29 | regulation of plasminogen activation (GO:0010755) | 3.21886938 |
30 | viral transcription (GO:0019083) | 3.21723469 |
31 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 3.20581870 |
32 | skin morphogenesis (GO:0043589) | 3.19694100 |
33 | GDP-mannose metabolic process (GO:0019673) | 3.19154712 |
34 | membrane budding (GO:0006900) | 3.16346721 |
35 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.16238229 |
36 | protein localization to endoplasmic reticulum (GO:0070972) | 3.15884632 |
37 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.14840890 |
38 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.12964068 |
39 | response to redox state (GO:0051775) | 3.09251387 |
40 | chaperone-mediated protein transport (GO:0072321) | 3.08333107 |
41 | translational termination (GO:0006415) | 3.08094884 |
42 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.06093386 |
43 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.04306031 |
44 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.00747912 |
45 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.00715423 |
46 | cyclooxygenase pathway (GO:0019371) | 2.98588231 |
47 | protein localization to endosome (GO:0036010) | 2.98482010 |
48 | negative regulation of anoikis (GO:2000811) | 2.97011856 |
49 | nuclear envelope reassembly (GO:0031468) | 2.90223603 |
50 | mitotic nuclear envelope reassembly (GO:0007084) | 2.90223603 |
51 | regulation of mitotic spindle organization (GO:0060236) | 2.85556958 |
52 | translation (GO:0006412) | 2.83809578 |
53 | regulation of protein export from nucleus (GO:0046825) | 2.77823047 |
54 | endodermal cell differentiation (GO:0035987) | 2.77255810 |
55 | barbed-end actin filament capping (GO:0051016) | 2.72491321 |
56 | desmosome organization (GO:0002934) | 2.72342678 |
57 | regulation of vitamin metabolic process (GO:0030656) | 2.70720548 |
58 | viral life cycle (GO:0019058) | 2.69778320 |
59 | cellular response to interferon-alpha (GO:0035457) | 2.68335631 |
60 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.67591297 |
61 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.65411988 |
62 | cell-substrate junction assembly (GO:0007044) | 2.65128583 |
63 | regulation of spindle organization (GO:0090224) | 2.63300987 |
64 | establishment of viral latency (GO:0019043) | 2.61655686 |
65 | translational elongation (GO:0006414) | 2.60328476 |
66 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.58630687 |
67 | establishment of integrated proviral latency (GO:0075713) | 2.58621151 |
68 | AMP metabolic process (GO:0046033) | 2.58474741 |
69 | nucleotide salvage (GO:0043173) | 2.58321883 |
70 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.57454229 |
71 | negative regulation of ligase activity (GO:0051352) | 2.57454229 |
72 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.56691425 |
73 | protein targeting to membrane (GO:0006612) | 2.56210941 |
74 | regulation of anoikis (GO:2000209) | 2.56060930 |
75 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.54453742 |
76 | translational initiation (GO:0006413) | 2.53717923 |
77 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.51846015 |
78 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 2.51437252 |
79 | UMP metabolic process (GO:0046049) | 2.51437252 |
80 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 2.51437252 |
81 | UMP biosynthetic process (GO:0006222) | 2.51437252 |
82 | ATP synthesis coupled proton transport (GO:0015986) | 2.50645089 |
83 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.50645089 |
84 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.47878784 |
85 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.46957885 |
86 | protein targeting to mitochondrion (GO:0006626) | 2.46861630 |
87 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.46652813 |
88 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.46652813 |
89 | negative regulation of fibrinolysis (GO:0051918) | 2.45134879 |
90 | response to copper ion (GO:0046688) | 2.44755237 |
91 | natural killer cell mediated immunity (GO:0002228) | 2.44739362 |
92 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.44739362 |
93 | activation of protein kinase B activity (GO:0032148) | 2.43852871 |
94 | parturition (GO:0007567) | 2.43757160 |
95 | mitotic metaphase plate congression (GO:0007080) | 2.42745512 |
96 | rRNA modification (GO:0000154) | 2.42236540 |
97 | ribosome assembly (GO:0042255) | 2.40826207 |
98 | Golgi transport vesicle coating (GO:0048200) | 2.39737720 |
99 | COPI coating of Golgi vesicle (GO:0048205) | 2.39737720 |
100 | * cellular response to zinc ion (GO:0071294) | 13.6319213 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.87450735 |
2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.58260552 |
3 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 3.66726579 |
4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.82943650 |
5 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.68401851 |
6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.66503329 |
7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.58884398 |
8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.43404490 |
9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.37235308 |
10 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.36564577 |
11 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 2.32767389 |
12 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.31339707 |
13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.30586114 |
14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.20280061 |
15 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.20100000 |
16 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.04846840 |
17 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.04846840 |
18 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.00516046 |
19 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.94911459 |
20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.94404404 |
21 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.87237431 |
22 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.85476993 |
23 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.85208276 |
24 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.82477881 |
25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.81876671 |
26 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.80187651 |
27 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.78813033 |
28 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.78508629 |
29 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.76915141 |
30 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.76797601 |
31 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.73605582 |
32 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.73063129 |
33 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.71117296 |
34 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.70953199 |
35 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.69812598 |
36 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.68441379 |
37 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.68426414 |
38 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.67731037 |
39 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.62875084 |
40 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.60881759 |
41 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.60600997 |
42 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.60390020 |
43 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.59316639 |
44 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.59108651 |
45 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.57108979 |
46 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.50998232 |
47 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.49954814 |
48 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.48786285 |
49 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.48323947 |
50 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.47495282 |
51 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.45099758 |
52 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.45007354 |
53 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.44782243 |
54 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.44282267 |
55 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.36568204 |
56 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.34650909 |
57 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.32264185 |
58 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.30939946 |
59 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.28898517 |
60 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.26876317 |
61 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.26628613 |
62 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.25940059 |
63 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.23212691 |
64 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.22003855 |
65 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.20000414 |
66 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.19567590 |
67 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.18786413 |
68 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.18260411 |
69 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.17915383 |
70 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15897958 |
71 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.14405858 |
72 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.13516748 |
73 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.13211707 |
74 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.12831241 |
75 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.11832705 |
76 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.11659703 |
77 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.11017803 |
78 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.09214009 |
79 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08930410 |
80 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.07094520 |
81 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.07024461 |
82 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06774151 |
83 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.06558674 |
84 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.04620811 |
85 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.02886265 |
86 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02031503 |
87 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.01361428 |
88 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.01211327 |
89 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.00849774 |
90 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.00702381 |
91 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.98571043 |
92 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.98404989 |
93 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.97536684 |
94 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.97444224 |
95 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.97321309 |
96 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95554459 |
97 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.94696820 |
98 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.93486245 |
99 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.92784942 |
100 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92611065 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003806_abnormal_nucleotide_metabolis | 5.50955052 |
2 | MP0003950_abnormal_plasma_membrane | 4.96089044 |
3 | MP0003705_abnormal_hypodermis_morpholog | 4.22103079 |
4 | MP0010368_abnormal_lymphatic_system | 3.60792550 |
5 | MP0008438_abnormal_cutaneous_collagen | 3.51757059 |
6 | MP0005360_urolithiasis | 2.81807625 |
7 | MP0003566_abnormal_cell_adhesion | 2.65791354 |
8 | MP0003191_abnormal_cellular_cholesterol | 2.56611201 |
9 | MP0005023_abnormal_wound_healing | 2.51279886 |
10 | MP0009780_abnormal_chondrocyte_physiolo | 2.32865237 |
11 | MP0001853_heart_inflammation | 2.29876421 |
12 | MP0010030_abnormal_orbit_morphology | 2.28437837 |
13 | MP0004272_abnormal_basement_membrane | 2.27034130 |
14 | MP0005623_abnormal_meninges_morphology | 2.25834410 |
15 | MP0006054_spinal_hemorrhage | 2.22997190 |
16 | MP0004510_myositis | 2.15456158 |
17 | MP0001879_abnormal_lymphatic_vessel | 2.14057017 |
18 | MP0003941_abnormal_skin_development | 2.06167310 |
19 | MP0003186_abnormal_redox_activity | 1.96395876 |
20 | MP0003279_aneurysm | 1.95838200 |
21 | MP0002060_abnormal_skin_morphology | 1.90019354 |
22 | MP0003453_abnormal_keratinocyte_physiol | 1.71996969 |
23 | MP0009840_abnormal_foam_cell | 1.70367768 |
24 | MP0002877_abnormal_melanocyte_morpholog | 1.68400957 |
25 | MP0000858_altered_metastatic_potential | 1.65696252 |
26 | MP0000343_altered_response_to | 1.65550358 |
27 | MP0005257_abnormal_intraocular_pressure | 1.59279758 |
28 | MP0001542_abnormal_bone_strength | 1.56879549 |
29 | MP0003091_abnormal_cell_migration | 1.56254697 |
30 | MP0005164_abnormal_response_to | 1.55038849 |
31 | MP0009053_abnormal_anal_canal | 1.54369590 |
32 | MP0000750_abnormal_muscle_regeneration | 1.51338247 |
33 | MP0005275_abnormal_skin_tensile | 1.50455703 |
34 | MP0000762_abnormal_tongue_morphology | 1.48553096 |
35 | MP0005451_abnormal_body_composition | 1.43682711 |
36 | MP0008007_abnormal_cellular_replicative | 1.39765668 |
37 | MP0002295_abnormal_pulmonary_circulatio | 1.36753399 |
38 | MP0009697_abnormal_copulation | 1.34235057 |
39 | MP0003075_altered_response_to | 1.31815675 |
40 | MP0001216_abnormal_epidermal_layer | 1.31496542 |
41 | MP0008260_abnormal_autophagy | 1.18513303 |
42 | MP0001958_emphysema | 1.18163484 |
43 | MP0000678_abnormal_parathyroid_gland | 1.18038031 |
44 | MP0005501_abnormal_skin_physiology | 1.17519232 |
45 | MP0002332_abnormal_exercise_endurance | 1.15776554 |
46 | MP0005165_increased_susceptibility_to | 1.14869811 |
47 | MP0005330_cardiomyopathy | 1.13230865 |
48 | MP0005670_abnormal_white_adipose | 1.12368652 |
49 | MP0005595_abnormal_vascular_smooth | 1.11487901 |
50 | MP0003448_altered_tumor_morphology | 1.09478129 |
51 | MP0000733_abnormal_muscle_development | 1.07292332 |
52 | MP0002796_impaired_skin_barrier | 1.06979793 |
53 | MP0000749_muscle_degeneration | 1.06667470 |
54 | MP0004883_abnormal_blood_vessel | 1.04529295 |
55 | MP0009379_abnormal_foot_pigmentation | 1.01992813 |
56 | MP0004947_skin_inflammation | 1.00241326 |
57 | MP0003828_pulmonary_edema | 0.98864443 |
58 | MP0000013_abnormal_adipose_tissue | 0.98519690 |
59 | MP0002148_abnormal_hypersensitivity_rea | 0.97821728 |
60 | MP0001243_abnormal_dermal_layer | 0.97214932 |
61 | MP0001849_ear_inflammation | 0.94454315 |
62 | MP0005166_decreased_susceptibility_to | 0.93721928 |
63 | MP0001881_abnormal_mammary_gland | 0.90782008 |
64 | MP0002896_abnormal_bone_mineralization | 0.89950233 |
65 | MP0006036_abnormal_mitochondrial_physio | 0.88918137 |
66 | MP0010771_integument_phenotype | 0.85889810 |
67 | MP0010352_gastrointestinal_tract_polyps | 0.84622134 |
68 | MP0005375_adipose_tissue_phenotype | 0.82585306 |
69 | MP0000358_abnormal_cell_content/ | 0.82489989 |
70 | MP0002234_abnormal_pharynx_morphology | 0.81026911 |
71 | MP0003077_abnormal_cell_cycle | 0.80396707 |
72 | MP0004233_abnormal_muscle_weight | 0.79200769 |
73 | MP0000579_abnormal_nail_morphology | 0.78906113 |
74 | MP0004957_abnormal_blastocyst_morpholog | 0.78033203 |
75 | MP0009785_altered_susceptibility_to | 0.76894388 |
76 | MP0005193_abnormal_anterior_eye | 0.73917463 |
77 | MP0005666_abnormal_adipose_tissue | 0.72956401 |
78 | MP0005621_abnormal_cell_physiology | 0.72825794 |
79 | MP0003011_delayed_dark_adaptation | 0.72365117 |
80 | MP0002938_white_spotting | 0.71101658 |
81 | MP0000767_abnormal_smooth_muscle | 0.70265858 |
82 | MP0009763_increased_sensitivity_to | 0.68300128 |
83 | MP0005058_abnormal_lysosome_morphology | 0.68101924 |
84 | MP0000350_abnormal_cell_proliferation | 0.68062850 |
85 | MP0005508_abnormal_skeleton_morphology | 0.66734713 |
86 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.66523008 |
87 | MP0001851_eye_inflammation | 0.63618247 |
88 | MP0009931_abnormal_skin_appearance | 0.63174605 |
89 | MP0000759_abnormal_skeletal_muscle | 0.62340157 |
90 | MP0005197_abnormal_uvea_morphology | 0.61833691 |
91 | MP0000003_abnormal_adipose_tissue | 0.61792636 |
92 | MP0000627_abnormal_mammary_gland | 0.61382744 |
93 | MP0009250_abnormal_appendicular_skeleto | 0.60901440 |
94 | MP0003045_fibrosis | 0.60894901 |
95 | MP0005395_other_phenotype | 0.60744794 |
96 | MP0003786_premature_aging | 0.60191187 |
97 | MP0009764_decreased_sensitivity_to | 0.59981722 |
98 | MP0010234_abnormal_vibrissa_follicle | 0.59947105 |
99 | MP0008875_abnormal_xenobiotic_pharmacok | 0.59942364 |
100 | MP0005408_hypopigmentation | 0.59911352 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Premature rupture of membranes (HP:0001788) | 3.95661243 |
2 | Atrophic scars (HP:0001075) | 3.88353964 |
3 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.62516549 |
4 | Onycholysis (HP:0001806) | 3.41900021 |
5 | Ankle contracture (HP:0006466) | 3.33773375 |
6 | Axonal loss (HP:0003447) | 3.31076777 |
7 | Abnormality of the intrinsic pathway (HP:0010989) | 3.26420769 |
8 | Protrusio acetabuli (HP:0003179) | 3.20954148 |
9 | Fragile nails (HP:0001808) | 3.18282406 |
10 | Amniotic constriction ring (HP:0009775) | 3.14894864 |
11 | Abnormality of placental membranes (HP:0011409) | 3.14894864 |
12 | Milia (HP:0001056) | 3.12418058 |
13 | Vertebral compression fractures (HP:0002953) | 3.05972790 |
14 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.02185586 |
15 | Nail dystrophy (HP:0008404) | 3.01493376 |
16 | Follicular hyperkeratosis (HP:0007502) | 2.89732750 |
17 | Generalized amyotrophy (HP:0003700) | 2.75895554 |
18 | Acute necrotizing encephalopathy (HP:0006965) | 2.75030878 |
19 | Vascular tortuosity (HP:0004948) | 2.73324175 |
20 | Rough bone trabeculation (HP:0100670) | 2.71878923 |
21 | Fragile skin (HP:0001030) | 2.71328800 |
22 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.69668041 |
23 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.65533082 |
24 | Natal tooth (HP:0000695) | 2.62416226 |
25 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.62011898 |
26 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.62011898 |
27 | Reduced antithrombin III activity (HP:0001976) | 2.58533122 |
28 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.56378188 |
29 | Alopecia of scalp (HP:0002293) | 2.55493255 |
30 | Lip pit (HP:0100267) | 2.54366143 |
31 | Decreased subcutaneous fat (HP:0001002) | 2.53692102 |
32 | Cardiovascular calcification (HP:0011915) | 2.50607453 |
33 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.48789581 |
34 | Osteolytic defects of the hand bones (HP:0009699) | 2.44334843 |
35 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.44334843 |
36 | Cervical subluxation (HP:0003308) | 2.41306038 |
37 | Type I transferrin isoform profile (HP:0003642) | 2.40225444 |
38 | Vascular calcification (HP:0004934) | 2.38380533 |
39 | Short nail (HP:0001799) | 2.35241206 |
40 | Sparse eyelashes (HP:0000653) | 2.31727820 |
41 | Stenosis of the external auditory canal (HP:0000402) | 2.29677940 |
42 | Spinal cord compression (HP:0002176) | 2.29040797 |
43 | Spinal rigidity (HP:0003306) | 2.28438721 |
44 | Renal Fanconi syndrome (HP:0001994) | 2.25051181 |
45 | Glucose intolerance (HP:0000833) | 2.24728761 |
46 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.22921475 |
47 | Abnormal trabecular bone morphology (HP:0100671) | 2.22582960 |
48 | Progressive macrocephaly (HP:0004481) | 2.21092485 |
49 | Thick nail (HP:0001805) | 2.19429654 |
50 | Wormian bones (HP:0002645) | 2.18566223 |
51 | Posterior subcapsular cataract (HP:0007787) | 2.17453394 |
52 | Acute encephalopathy (HP:0006846) | 2.17011184 |
53 | Neoplasm of head and neck (HP:0012288) | 2.16996391 |
54 | Esophageal neoplasm (HP:0100751) | 2.16996391 |
55 | Prolonged partial thromboplastin time (HP:0003645) | 2.14564315 |
56 | Entropion (HP:0000621) | 2.13592918 |
57 | Trismus (HP:0000211) | 2.13553377 |
58 | Mitochondrial inheritance (HP:0001427) | 2.10597725 |
59 | Bone cyst (HP:0012062) | 2.09904077 |
60 | Elbow flexion contracture (HP:0002987) | 2.07541918 |
61 | Distal lower limb muscle weakness (HP:0009053) | 2.06890928 |
62 | Palpitations (HP:0001962) | 2.05681505 |
63 | Plantar hyperkeratosis (HP:0007556) | 2.02877965 |
64 | Abnormality of subcutaneous fat tissue (HP:0001001) | 2.01498765 |
65 | Distal lower limb amyotrophy (HP:0008944) | 2.00946958 |
66 | Achilles tendon contracture (HP:0001771) | 2.00562710 |
67 | Testicular atrophy (HP:0000029) | 2.00485261 |
68 | Macrocytic anemia (HP:0001972) | 2.00158045 |
69 | Hypertensive crisis (HP:0100735) | 1.99791212 |
70 | Renal duplication (HP:0000075) | 1.97317774 |
71 | Generalized aminoaciduria (HP:0002909) | 1.96954953 |
72 | Hypoplasia of dental enamel (HP:0006297) | 1.96339564 |
73 | Aortic aneurysm (HP:0004942) | 1.95574258 |
74 | Conjunctival hamartoma (HP:0100780) | 1.93866271 |
75 | Hyperparathyroidism (HP:0000843) | 1.93389405 |
76 | Acanthosis nigricans (HP:0000956) | 1.92771886 |
77 | Abnormality of methionine metabolism (HP:0010901) | 1.92242998 |
78 | Blue sclerae (HP:0000592) | 1.90769472 |
79 | Arterial tortuosity (HP:0005116) | 1.90559633 |
80 | Abnormality of the umbilical cord (HP:0010881) | 1.90247722 |
81 | Oral leukoplakia (HP:0002745) | 1.83797882 |
82 | Abnormal gallbladder physiology (HP:0012438) | 1.83245187 |
83 | Cholecystitis (HP:0001082) | 1.83245187 |
84 | Abnormality of the Achilles tendon (HP:0005109) | 1.83143043 |
85 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.83045321 |
86 | Aortic dissection (HP:0002647) | 1.81215834 |
87 | Exercise intolerance (HP:0003546) | 1.78082608 |
88 | Insulin resistance (HP:0000855) | 1.77662522 |
89 | Chondrocalcinosis (HP:0000934) | 1.76867891 |
90 | Abnormality of complement system (HP:0005339) | 1.75310835 |
91 | Abnormality of carpal bone ossification (HP:0006257) | 1.75200075 |
92 | Poikiloderma (HP:0001029) | 1.74540893 |
93 | Exertional dyspnea (HP:0002875) | 1.74352829 |
94 | Bladder diverticulum (HP:0000015) | 1.73472934 |
95 | Abnormality of Sharpey fibers (HP:0100685) | 1.73242263 |
96 | Abnormal number of erythroid precursors (HP:0012131) | 1.73025927 |
97 | Brittle hair (HP:0002299) | 1.72963928 |
98 | Increased CSF lactate (HP:0002490) | 1.70201962 |
99 | Hypoplastic pelvis (HP:0008839) | 1.70088373 |
100 | Abnormal blistering of the skin (HP:0008066) | 1.69934625 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ARAF | 4.09242895 |
2 | NME2 | 3.62721309 |
3 | IRAK3 | 3.17401926 |
4 | MAP3K12 | 3.02071037 |
5 | BUB1 | 2.92723820 |
6 | PAK4 | 2.73862071 |
7 | PIM2 | 2.71345511 |
8 | NEK1 | 2.47797765 |
9 | TESK1 | 2.41014194 |
10 | PTK2 | 2.31262799 |
11 | MST1R | 2.28796646 |
12 | MST4 | 2.26980598 |
13 | LATS2 | 2.25143614 |
14 | MYLK | 2.22760079 |
15 | MAP3K3 | 2.21497534 |
16 | MOS | 2.21371339 |
17 | ABL2 | 2.15072434 |
18 | EPHA2 | 2.06776199 |
19 | TGFBR2 | 2.06540901 |
20 | LIMK1 | 2.02965176 |
21 | MET | 1.88403964 |
22 | EPHB2 | 1.87630305 |
23 | PDGFRA | 1.75302157 |
24 | ERBB4 | 1.73504603 |
25 | EIF2AK1 | 1.66573732 |
26 | RIPK1 | 1.66095542 |
27 | ILK | 1.62330334 |
28 | STK16 | 1.61411311 |
29 | LMTK2 | 1.54961927 |
30 | VRK2 | 1.52719750 |
31 | BRAF | 1.52585541 |
32 | PBK | 1.50658576 |
33 | FLT3 | 1.49404237 |
34 | NTRK1 | 1.34841424 |
35 | STK10 | 1.25980332 |
36 | ERN1 | 1.22778479 |
37 | DDR2 | 1.21038860 |
38 | TAOK2 | 1.20321821 |
39 | EIF2AK3 | 1.07447369 |
40 | PAK2 | 1.06508988 |
41 | EPHB1 | 0.98714871 |
42 | CLK1 | 0.97934587 |
43 | PRPF4B | 0.93085669 |
44 | PDK2 | 0.85075100 |
45 | PAK1 | 0.76706518 |
46 | PRKG2 | 0.76520625 |
47 | AURKA | 0.75528016 |
48 | GRK7 | 0.75013422 |
49 | CDK8 | 0.71334127 |
50 | MAP3K9 | 0.70253975 |
51 | MAP3K8 | 0.69014920 |
52 | RAF1 | 0.68733375 |
53 | TESK2 | 0.68357591 |
54 | PAK6 | 0.68196134 |
55 | MUSK | 0.67227456 |
56 | DMPK | 0.66211884 |
57 | TTN | 0.64925177 |
58 | PRKCI | 0.63047778 |
59 | ADRBK1 | 0.62640831 |
60 | STK24 | 0.62010646 |
61 | ROCK2 | 0.61812246 |
62 | STK38 | 0.60793597 |
63 | PTK2B | 0.58722495 |
64 | CCNB1 | 0.57172865 |
65 | MAP2K3 | 0.56421506 |
66 | MAP3K13 | 0.55799207 |
67 | CDK9 | 0.51036401 |
68 | GSK3A | 0.50377816 |
69 | PHKG1 | 0.49134919 |
70 | PHKG2 | 0.49134919 |
71 | DAPK3 | 0.49132317 |
72 | EIF2AK2 | 0.49107624 |
73 | AKT2 | 0.49077948 |
74 | CDC7 | 0.48756884 |
75 | BRSK1 | 0.47385964 |
76 | AURKB | 0.46961484 |
77 | CAMK2G | 0.46917236 |
78 | BMX | 0.43626836 |
79 | ROCK1 | 0.43556061 |
80 | NEK2 | 0.43174244 |
81 | TBK1 | 0.42800223 |
82 | BCKDK | 0.40963366 |
83 | PDGFRB | 0.40187460 |
84 | TRIB3 | 0.39011271 |
85 | NEK9 | 0.38117978 |
86 | SIK1 | 0.37887719 |
87 | NME1 | 0.36456994 |
88 | DAPK1 | 0.32785164 |
89 | PLK1 | 0.32449677 |
90 | GRK5 | 0.30115566 |
91 | MAPKAPK2 | 0.29604453 |
92 | MELK | 0.28241008 |
93 | STK4 | 0.27558963 |
94 | LRRK2 | 0.27319071 |
95 | SRPK1 | 0.24930430 |
96 | CSNK1A1L | 0.24161315 |
97 | CDC42BPA | 0.23665189 |
98 | PLK3 | 0.23607949 |
99 | PRKD2 | 0.22822933 |
100 | PTK6 | 0.22230879 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome_Homo sapiens_hsa03010 | 4.53469454 |
2 | Proteasome_Homo sapiens_hsa03050 | 4.04222155 |
3 | * Mineral absorption_Homo sapiens_hsa04978 | 3.63166645 |
4 | Protein export_Homo sapiens_hsa03060 | 2.93772642 |
5 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.68453301 |
6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.67941425 |
7 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.59017587 |
8 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.11417638 |
9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.05517565 |
10 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.95385740 |
11 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.92301587 |
12 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.86385592 |
13 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.74398152 |
14 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.71696077 |
15 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.70843982 |
16 | Alzheimers disease_Homo sapiens_hsa05010 | 1.70280845 |
17 | DNA replication_Homo sapiens_hsa03030 | 1.67306617 |
18 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.66857974 |
19 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.66656128 |
20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.63329367 |
21 | Huntingtons disease_Homo sapiens_hsa05016 | 1.55851701 |
22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.51857265 |
23 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.49626059 |
24 | Shigellosis_Homo sapiens_hsa05131 | 1.48311424 |
25 | Mismatch repair_Homo sapiens_hsa03430 | 1.43859533 |
26 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.40288019 |
27 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.40157218 |
28 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.38135076 |
29 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.35304606 |
30 | RNA polymerase_Homo sapiens_hsa03020 | 1.32010533 |
31 | Galactose metabolism_Homo sapiens_hsa00052 | 1.31377225 |
32 | Salmonella infection_Homo sapiens_hsa05132 | 1.29055525 |
33 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.26185201 |
34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.24243911 |
35 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.19219082 |
36 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.18403951 |
37 | Sulfur relay system_Homo sapiens_hsa04122 | 1.16920856 |
38 | Focal adhesion_Homo sapiens_hsa04510 | 1.12485098 |
39 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.11374610 |
40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.11047126 |
41 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.03020515 |
42 | Prion diseases_Homo sapiens_hsa05020 | 0.99643749 |
43 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.98954943 |
44 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.95773105 |
45 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.91689480 |
46 | Homologous recombination_Homo sapiens_hsa03440 | 0.83643476 |
47 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.82603795 |
48 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.81356191 |
49 | Bladder cancer_Homo sapiens_hsa05219 | 0.81078271 |
50 | Pertussis_Homo sapiens_hsa05133 | 0.81063019 |
51 | Base excision repair_Homo sapiens_hsa03410 | 0.78580300 |
52 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.74954323 |
53 | Malaria_Homo sapiens_hsa05144 | 0.74949803 |
54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.70819724 |
55 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.67783128 |
56 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.67535793 |
57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.67171321 |
58 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.66602744 |
59 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.64867063 |
60 | Amoebiasis_Homo sapiens_hsa05146 | 0.64136746 |
61 | Legionellosis_Homo sapiens_hsa05134 | 0.64093157 |
62 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61547782 |
63 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.59567359 |
64 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.59496840 |
65 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58768431 |
66 | Circadian rhythm_Homo sapiens_hsa04710 | 0.58154875 |
67 | Basal transcription factors_Homo sapiens_hsa03022 | 0.56856830 |
68 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.56139952 |
69 | Carbon metabolism_Homo sapiens_hsa01200 | 0.55794335 |
70 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.54815441 |
71 | Apoptosis_Homo sapiens_hsa04210 | 0.54006097 |
72 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.52600201 |
73 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52306824 |
74 | Endocytosis_Homo sapiens_hsa04144 | 0.50251830 |
75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49296963 |
76 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.48783505 |
77 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47505713 |
78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46567167 |
79 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.43200403 |
80 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.42172756 |
81 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.41827163 |
82 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.41218721 |
83 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.40945674 |
84 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.40664320 |
85 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.39976983 |
86 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.39798459 |
87 | Cell cycle_Homo sapiens_hsa04110 | 0.37515157 |
88 | RNA transport_Homo sapiens_hsa03013 | 0.35853281 |
89 | Purine metabolism_Homo sapiens_hsa00230 | 0.35636556 |
90 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.35128789 |
91 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.34663342 |
92 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.33879304 |
93 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.32816375 |
94 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.32740438 |
95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.31240048 |
96 | Adherens junction_Homo sapiens_hsa04520 | 0.31039570 |
97 | Lysosome_Homo sapiens_hsa04142 | 0.30998886 |
98 | Spliceosome_Homo sapiens_hsa03040 | 0.30372795 |
99 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.30050594 |
100 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.29102602 |